|
WASF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.376620E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.838640E-01 |
| Normal-vs-Stage2 |
9.978000E-01 |
| Normal-vs-Stage3 |
8.661200E-01 |
| Normal-vs-Stage4 |
9.912600E-01 |
| Stage1-vs-Stage2 |
3.358200E-01 |
| Stage1-vs-Stage3 |
3.389800E-01 |
| Stage1-vs-Stage4 |
6.005000E-01 |
| Stage2-vs-Stage3 |
8.819000E-01 |
| Stage2-vs-Stage4 |
9.913600E-01 |
| Stage3-vs-Stage4 |
9.307800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.748600E-01 |
| Normal-vs-AfricanAmerican |
1.434750E-01 |
| Normal-vs-Asian |
2.315000E-01 |
| Caucasian-vs-AfricanAmerican |
5.518800E-01 |
| Caucasian-vs-Asian |
1.170580E-01 |
| AfricanAmerican-vs-Asian |
5.129500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.647000E-01 |
| Normal-vs-Female |
3.757900E-02 |
| Male-vs-Female |
1.079150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.084400E-01 |
| Normal-vs-Extreme_Weight |
6.281200E-01 |
| Normal-vs-Obese |
1.372160E-01 |
| Normal-vs-Extreme_Obese |
7.458200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.906400E-01 |
| Normal_Weight-vs-Obese |
5.286400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.606200E-01 |
| Extreme_Weight-vs-Obese |
3.602600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.919000E-01 |
| Obese-vs-Extreme_Obese |
3.642800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.284650E-01 |
| Normal-vs-Age(41-60Yrs) |
2.494500E-02 |
| Normal-vs-Age(61-80Yrs) |
9.641000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.618600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.638200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.461500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.847200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.827700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.687800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.901600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.394050E-02 |
| Normal-VS-Type2 PRCC |
5.976000E-02 |
| Normal-VS-KIRP CIMP |
4.277900E-02 |
| Normal-VS-Unclassified PRCC |
9.199900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.5475000000047E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.680830E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.280200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.097800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.079500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.365200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.461600E-01 |
| Normal-vs-N1 |
7.701400E-01 |
| Normal-vs-N2 |
3.166000E-01 |
| N0-vs-N1 |
2.937400E-01 |
| N0-vs-N2 |
5.134400E-02 |
| N1-vs-N2 |
3.140800E-01 |
|
|
